Cargando…
STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs
SIMPLE SUMMARY: Despite recent improvements in survival rates, colorectal cancer is still responsible for millions of premature deaths worldwide. A better understanding of the steps that lead from chronic inflammation to cancer progression could offer new therapeutic options and save many lives. The...
Autores principales: | Chiriac, Mircea T., Hracsko, Zsuzsanna, Becker, Christoph, Neurath, Markus F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670206/ https://www.ncbi.nlm.nih.gov/pubmed/38001683 http://dx.doi.org/10.3390/cancers15225423 |
Ejemplares similares
-
An IFN-STAT Axis Augments Tissue Damage and Inflammation in a Mouse Model of Crohn's Disease
por: Stolzer, Iris, et al.
Publicado: (2021) -
IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer
por: Sakahara, Mizuho, et al.
Publicado: (2019) -
STAT1 coordinates intestinal epithelial cell death during gastrointestinal infection upstream of Caspase-8
por: Stolzer, Iris, et al.
Publicado: (2021) -
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer
por: Waldner, Maximilian J., et al.
Publicado: (2010) -
Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer
por: Zundler, Sebastian, et al.
Publicado: (2016)